Strattera 80mg Dosing: Single vs. Split Dose
Strattera (atomoxetine) 80 mg can be taken either as a single daily dose in the morning OR split into two evenly divided doses (morning and late afternoon/early evening), with both approaches being FDA-approved and equally effective. 1
FDA-Approved Dosing Options
The FDA label explicitly states that for patients over 70 kg body weight and adults, the target dose of 80 mg can be administered:
- Once daily in the morning, OR
- As evenly divided doses in the morning and late afternoon/early evening 1
Both dosing strategies are officially approved with no preference stated in the prescribing information.
Choosing Between Once vs. Twice Daily Dosing
When to consider splitting the dose (BID):
- To reduce gastrointestinal side effects: Twice-daily dosing significantly reduces nausea (16.4% vs 32.4% with once-daily dosing) 2
- For better tolerability during initiation: Splitting doses and slower titration over 2 weeks reduces early adverse events, particularly decreased appetite (8.0% vs 14.3%) and somnolence (4.2% vs 14.3%) 3
- To improve oppositional symptoms at home: One study found BID dosing improved ODD symptoms that hadn't responded to once-daily dosing 4
- If evening coverage is needed: Split dosing provides more consistent "around-the-clock" effects 5
When once-daily dosing is appropriate:
- For adherence: Single morning dose is simpler and may improve medication compliance
- When well-tolerated: If the patient tolerates 80 mg once daily without significant side effects
- For daytime-only coverage: Morning dosing has been shown effective into the evening 6
Practical Implementation
Start conservatively: Begin with twice-daily dosing (40 mg morning, 40 mg late afternoon) during initial titration to minimize side effects, then consolidate to once-daily if preferred and well-tolerated 3.
Common pitfall: Don't assume once-daily dosing is always superior. While simpler, it causes significantly more nausea in adults (32.4% vs 16.4%) 2. If gastrointestinal side effects emerge on once-daily dosing, switch to split dosing rather than discontinuing the medication.
Timing for split dose: The second dose should be given in late afternoon/early evening, not at bedtime, to maintain coverage while avoiding sleep interference 1.
Safety Considerations
Both dosing strategies show equivalent safety profiles overall, with no unexpected adverse events in either approach 2. The choice does not affect cardiovascular monitoring requirements, which remain the same regardless of dosing frequency 5.
Key monitoring remains identical: Track suicidality (especially in youth), blood pressure, pulse, appetite, and growth parameters regardless of whether dosing is once or twice daily 5, 1.